| Stage | ENS | % of rev | NOVT | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $936M | 100.00% | $266M | 100.00% | ENS ×3.52 |
| Gross profit | $313M | 33.49% | $121M | 45.49% | NOVT +12.0pp |
| Operating income | $151M | 16.18% | $18M | 6.79% | ENS +9.4pp |
| Pre-tax income | $135M | 14.43% | $16M | 5.98% | ENS +8.4pp |
| Net income | $116M | 12.45% | $13M | 4.72% | ENS +7.7pp |
| Stage | ENS | NOVT | Gap · A − B |
|---|---|---|---|
| Revenue | $936M100.00% | $266M100.00% | ENS ×3.52 |
| Gross profit | 33.49%$313M | 45.49%$121M | NOVT +12.0pp |
| Operating income | 16.18%$151M | 6.79%$18M | ENS +9.4pp |
| Pre-tax income | 14.43%$135M | 5.98%$16M | ENS +8.4pp |
| Net income |
| 12.45%$116M |
| 4.72%$13M |
| ENS +7.7pp |
No disclosed counterparties: NOVT.
None